You are here

  • Home
  • Archive
  • Volume 11, Issue 9
  • BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer

Article metrics

Article menu

Download PDFPDF

Diagnostics
Protocol
BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer

 

Online download statistics by month:

Online download statistics by month: September 2021 to October 2024

AbstractFullPdf
Sep 202130930891
Oct 2021302294117
Nov 202120820661
Dec 202120520159
Jan 202218117857
Feb 202214515174
Mar 202213313755
Apr 202212512637
May 2022636461
Jun 202212310035
Jul 2022847745
Aug 2022807849
Sep 2022706443
Oct 2022565245
Nov 2022605437
Dec 2022443923
Jan 2023737061
Feb 2023635728
Mar 2023645832
Apr 2023484221
May 2023624730
Jun 2023494117
Jul 2023716819
Aug 2023867024
Sep 2023919311
Oct 202310810127
Nov 2023858315
Dec 2023939418
Jan 202421015849
Feb 202417017082
Mar 2024188188106
Apr 202414013544
May 202442742660
Jun 202412711747
Jul 202420820144
Aug 2024575137
Sep 2024544723
Oct 202416128
Total467844581692